Works matching IS 08991987 AND DT 2024 AND VI 63 AND IP 5

Results: 17

Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 5, p. 991, doi. 10.1002/mc.23703

By:

Song, Mengqiu;
Qu, Yingzi;
Jia, Huajie;
Zhang, Yunqing;
Liu, Shihui;
Laster, Kyle Vaughn;
Choi, Bu Young;
Tian, Jie;
Gu, Tingxuan;
Chen, Hanyong;
Liu, Kangdong;
Lee, Mee‐Hyun;
Dong, Zigang

Publication type:

Article

Cover Image, Volume 63, Issue 5.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 5, p. i, doi. 10.1002/mc.23733

By:

Song, Mengqiu;
Qu, Yingzi;
Jia, Huajie;
Zhang, Yunqing;
Liu, Shihui;
Laster, Kyle Vaughn;
Choi, Bu Young;
Tian, Jie;
Gu, Tingxuan;
Chen, Hanyong;
Liu, Kangdong;
Lee, Mee‐Hyun;
Dong, Zigang

Publication type:

Article

RhoGDIβ inhibition via miR‐200c/AUF1/SOX2/miR‐137 axis contributed to lncRNA MEG3 downregulation‐mediated malignant transformation of human bronchial epithelial cells.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 5, p. 977, doi. 10.1002/mc.23702

By:

Yang, Yichao;
Tian, Zhongxian;
He, Lijiong;
Meng, Hao;
Xie, Xiaomin;
Yang, Ziyi;
Wang, Xinxing;
Zhao, Yunping;
Huang, Chuanshu

Publication type:

Article

Glutaminase potentiates the glycolysis in esophageal squamous cell carcinoma by interacting with PDK1.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 5, p. 897, doi. 10.1002/mc.23696

By:

Zhu, Guangzhao;
Guan, Fangxia;
Li, Shenglei;
Zhang, Qing;
Zhang, Xueying;
Qin, Yue;
Sun, Zhangzhan;
Peng, Shaohua;
Cheng, Jiexing;
Li, Yiyang;
Ren, Ruili;
Fan, Tianli;
Liu, Hongtao

Publication type:

Article

EMX2 inhibits clear cell renal cell carcinoma progress via modulating Akt/FOXO3a pathway.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 5, p. 951, doi. 10.1002/mc.23700

By:

Zhou, Xiaofeng;
Dong, Sicheng;
Zhou, Yuhao;
He, Zhiqing;
Zhang, Zhixiong;
Liao, Liqiong;
Zou, Bangyu;
Zheng, Xiaopeng;
Peng, Kaoqing;
Duan, Xiaolu

Publication type:

Article

Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 5, p. 938, doi. 10.1002/mc.23699

By:

Chen, Qun;
Jiang, Lu‐Yang;
Cao, Cheng;
Liu, Feng‐Yuan;
Li, Dan‐Rui;
Wu, Peng‐Fei;
Jiang, Kui‐Rong

Publication type:

Article

FTO promotes the progression of retinoblastoma through YTHDF2‐dependent N6‐methyladenosine modification in E2F3.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 5, p. 926, doi. 10.1002/mc.23698

By:

Xie, Weiwei;
Shao, Yongqing;
Bo, Qingyun;
Li, Zhen;
Yu, Qihua;
Wang, Layi;
Wu, Guohai

Publication type:

Article

GOLPH3 promotes tumor malignancy via inhibition of ferroptosis by upregulating SLC7A11 in cholangiocarcinoma.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 5, p. 912, doi. 10.1002/mc.23697

By:

Yin, Zheng;
Liu, Qi;
Gao, Ying;
Wang, Ruizhi;
Qi, Yunling;
Wang, Dong;
Chen, Lianzhou;
Yin, Xiaoyu;
He, Meifang;
Li, Wen

Publication type:

Article

NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m<sup>5</sup>C‐dependent manner.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 5, p. 962, doi. 10.1002/mc.23701

By:

Du, Xuan;
Cheng, Cheng;
Yang, Yi;
Fan, Bowen;
Wang, Peiwen;
Xia, Haibo;
Ni, Xinye;
Liu, Qizhan;
Lu, Lu;
Wei, Lei

Publication type:

Article

KDM5B promotes metastasis and epithelial–mesenchymal transition via Wnt/β‐catenin pathway in squamous cell carcinoma of the head and neck.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 5, p. 885, doi. 10.1002/mc.23695

By:

Yuan, Wenhui;
Hu, Junli;
Wang, Mengshu;
Li, Guo;
Lu, Shanhong;
Qiu, Yuanzheng;
Liu, Chao;
Liu, Yong

Publication type:

Article

Neuronal CFL1 upregulation in head and neck squamous cell carcinoma enhances tumor‐nerve crosstalk and promotes tumor growth.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 5, p. 874, doi. 10.1002/mc.23694

By:

Liu, Ruoyan;
Wang, Chunli;
Sun, Zhonghao;
Shi, Xiaotian;
Zhang, Ze;
Luo, Jingtao

Publication type:

Article

Issue Information ‐ Ed Board.

Published in:: Molecular Carcinogenesis, 2024, v. 63, n. 5, p. 799, doi. 10.1002/mc.23574
Publication type:: Article

Drug‐target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 5, p. 849, doi. 10.1002/mc.23692

By:

Sun, Xiaohui;
Ping, Jie;
Guo, Xingyi;
Long, Jirong;
Cai, Qiuyin;
Shu, Xiao‐ou;
Shu, Xiang

Publication type:

Article

Tissue‐of‐origin for cancers determines HIF‐1 activation induced phenotypic heterogeneity.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 5, p. 834, doi. 10.1002/mc.23691

By:

Liu, Shaofei;
Liu, Yamin;
Qiu, Xihua;
Suhail, Yasir;
Kshitiz

Publication type:

Article

Prenatal arsenic exposure alters keratinocyte stem cell fate through persistent activation of IGF2R‐MAPK cascade leading to aggravated skin carcinogenesis in mice offspring.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 5, p. 817, doi. 10.1002/mc.23690

By:

Chauhan, Anchal;
Gangopadhyay, Siddhartha;
Sharma, Vineeta;
Singh, Sukhveer;
Koshta, Kavita;
Singh, Dhirendra;
Ansari, Kausar M.;
Srivastava, Vikas

Publication type:

Article

TMED3 stabilizes SMAD2 by counteracting NEDD4‐mediated ubiquitination to promote ovarian cancer.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 5, p. 803, doi. 10.1002/mc.23689

By:

Chen, Xiaojun;
Zhang, Wei;
Han, Xiaotian;
Li, Xiaoqi;
Xia, Lingfang;
Wu, Yong;
Zhou, Yang

Publication type:

Article

HNRNPC promotes estrogen receptor‐positive breast cancer cell cycle by stabilizing WDR77 mRNA in an m6A‐dependent manner.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 5, p. 859, doi. 10.1002/mc.23693

By:

Xu, Wenjie;
Huang, Ziwei;
Xiao, Yunxiao;
Li, Wenhui;
Xu, Ming;
Zhao, Qiuyang;
Yi, Pengfei

Publication type:

Article